Mount Sinai Hospital

A phase 2 clinical trial of a cholesterol-reducing drug called evinacumab has reported promising results. In patients with extremely high cholesterol, the drug was able to reduce levels by about half, compared to a placebo.

A new study is suggesting signs of the disease ALS may be detectable in teeth, decades before the onset of any symptoms. The research points to a dysfunction in metabolizing metals as a possible factor in the onset of this still mysterious disease.

The Mount Sinai Kyabirwa Surgical Facility is a superb project in Uganda that provides locals with access to much-needed surgical treatment. The facility makes good use of off-grid technology, including solar panels and rainwater collection systems.

New research reveals different types of fasting results in significantly different immune responses.

A new study suggests CBD can reduce cravings and anxiety in subjects with a history of heroin use. The study doesn't imply CBD alone can help break an opioid addiction but instead points to the marijuana ingredient acting as a tool to help reduce cravings in those struggling with heroin addiction.

After a heart attack this vital organ remains damaged, which can eventually lead to heart failure and death. Now, researchers have managed to use placental stem cells to regenerate heart cells in mice, which could lead to groundbreaking new treatments for heart attack victims.

​Scientists at New York's Icahn School of Medicine at Mount Sinai have made an exciting breakthrough in the realm of cancer treatment, describing a new way of supercharging the body's immune system so that it can take the upper hand and destroy tumor cells around the body.

​Mild to moderate asthma can be difficult to diagnose, as its symptoms change over time and are often affected by other respiratory conditions. A new test, however, is able to definitively determine whether or not a patient has asthma – via just a swabbing of the nose.​

​For many years, people suffering from dry eye disease have turned to omega-3 fatty acid supplements to help relive their symptoms. According to a new study funded by the US National Eye Institute (NEI), however, such supplements make virtually no difference.

There could be hope for people who have to spend lots of money on eye medication – no, the medicine won't be getting less expensive, but a bottle of it may last longer. That's because scientists have developed a microdosing system that's considerably more efficient than current technology.

By altering a single gene to inhibit the activity of an enzyme called phosphodiesterase (PDE4B), researchers have given the brainpower of mice a boost. The research could lead to new treatments for those with cognitive disorders and age-related cognitive decline.

For the first time ever, scientists from the University of Montreal and Mount Sinai Hospital have generated pluripotent stem cells from horses.